Paeds Vivas · infectious-diseases
Varicella and herpes zoster — branching viva
Branching structured-oral viva on varicella and herpes zoster: the neurotropic latency-and-reactivation biology, the clinical signature of successive vesicle crops, host-risk stratification, PCR and serology, antiviral therapy by tier, isolation and notification, post-exposure prophylaxis with vaccine or VZIG, and the two-dose varicella and recombinant zoster vaccine strategy.
On this page
Study tools
Target exams
Opening question
Examiner: Take me through this child. What is the diagnosis, and what is your frame for managing him? [1]
Candidate: The diagnosis is primary varicella. The combination of fever, a generalised vesicular rash with lesions of all stages — papules, vesicles, pustules and crusts — and a sibling with chickenpox two weeks ago makes the clinical diagnosis. The critical point is that this child is on maintenance chemotherapy, so he is a high-risk host in whom the disease can disseminate to the lungs, liver and brain. My frame is to treat him as high-risk from the first minute: admit, start intravenous aciclovir promptly, and run the public-health response to protect his contacts. [1] [4]
Examiner: Why is he at particular risk? [1]
Candidate: Because his cell-mediated immunity is suppressed by the chemotherapy, and it is cell-mediated immunity rather than antibody that holds varicella-zoster virus in check. In a host who cannot contain replication, the virus disseminates, producing fulminant pneumonia, hepatitis and encephalitis. The biology is the same as in a healthy child; the host turns a self-limiting illness into a life-threatening one. [1]
References6ShowHide
- [1]WHO Varicella and herpes zoster vaccines: WHO position paper, June 2014--Recommendations Vaccine, 2016.PMID 26723191
- [2]Marin M; Guris D; Chaves SS; Schmid S; Seward JF Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Recomm Rep, 2007.PMID 17585291
- [3]Harpaz R; Ortega-Sanchez IR; Seward JF Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Recomm Rep, 2008.PMID 18528318
- [4]Klassen TP; Belseck EM; Wiebe N; Hartling L Acyclovir for treating varicella in otherwise healthy children and adolescents Cochrane Database Syst Rev, 2005.PMID 16235308
- [5]Chaves SS; Gargiullo P; Zhang JX; Civen R; et al Varicella disease among vaccinated persons: clinical and epidemiological characteristics, 1997-2005 J Infect Dis, 2008.PMID 18419385
- [6]Enders G; Miller E; Cradock-Watson J; Bolley I; Ridehalgh M Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases Lancet, 1994.PMID 7802767